The performance of companies tied to iconic drugs like Viagra presents a challenging investment scenario . While the initial rise of copyright, fueled by Viagra's remarkable popularity, generated substantial returns, the expiry in key regions has introduced significant uncertainty . Investors are now assessing the effect of rival medications , dimi